A Framework for Documenting Medical Necessity

Medical necessity is the standard that payers apply to determine whether a service, treatment, or medication should be covered. It is also one of the most commonly cited reasons for denial. According to the AMA's 2023 Prior Authorization Physician Survey, 94% of physicians reported that prior authorization requirements delayed access to medically necessary care. Yet when these denials are appealed, the outcome often hinges not on whether the care was truly necessary, but on whether the necessity was adequately documented.

A structured approach to documenting medical necessity — built into the clinical workflow rather than assembled after a denial — is the most effective strategy for reducing both initial denials and the time spent on appeals.

What Payers Mean by Medical Necessity

The definition of medical necessity varies by payer and by state, but most definitions share common elements. A service is considered medically necessary when it is:

• Clinically appropriate in terms of type, frequency, extent, and duration
• Required to diagnose or treat the patient's condition
• Consistent with generally accepted standards of medical practice
• Not primarily for the convenience of the patient or provider
• The most appropriate level of service that can safely be provided

Understanding these criteria is essential because each one represents a potential point of denial. A payer may agree that a medication is appropriate for a condition but deny it because a less expensive alternative was not tried first. They may agree that imaging is needed but deny the specific modality as exceeding the appropriate level. Effective documentation must address all of these dimensions, not just the diagnosis-treatment link.

The Four-Element Framework

Practices that document medical necessity most effectively organize their clinical rationale around four elements. This framework ensures that the documentation addresses the core questions a payer reviewer will ask.

Element 1: Clinical Presentation

This is the starting point — the patient's current clinical status, documented with objective findings. It includes the diagnosis (with appropriate ICD-10 specificity), relevant symptoms and their severity, physical examination findings, and any measurable clinical data such as lab values, imaging results, or validated assessment scores.

The key requirement here is objectivity. A note stating "patient presents with significant pain" is subjective. A note stating "patient reports pain at 7/10 on the visual analog scale, localized to the right hip, limiting ambulation to less than one block without rest" is objective and measurable.

Element 2: Treatment History

Payers want to know what has already been tried. For most non-emergent treatments, the documentation should establish a clear history of prior interventions, including:

• Each therapy attempted (medication name, dose, route of administration)
• Duration of each trial (start and end dates)
• Clinical response or lack thereof (with measurable outcomes where possible)
• Reason for discontinuation (inadequate response, adverse reaction, contraindication)

This element is where many appeals fail. The physician may recall that the patient tried and failed two prior medications, but if the chart does not document the specific medications, the specific durations, and the specific outcomes, the appeal lacks the evidence needed to overcome a step therapy denial.

Element 3: Clinical Rationale

This is where the physician connects the clinical presentation and treatment history to the requested service. The rationale should explain why the specific treatment is appropriate for this patient, given their particular clinical circumstances.

Effective clinical rationale references published guidelines where applicable. For example: "Given the patient's T-score of -3.1, history of a prior fragility fracture, and inadequate response to 18 months of oral bisphosphonate therapy, anabolic therapy is recommended per the ASBMR 2024 guidelines for patients at very high fracture risk." This is not simply a statement of preference — it is a clinical argument grounded in evidence and directly tied to the patient's documented data.

Element 4: Consequences of Non-Treatment

This element is frequently overlooked but can be decisive in appeal outcomes. Documenting the expected consequences if the requested treatment is not provided — disease progression, functional decline, hospitalization risk, or other adverse outcomes — makes the medical necessity argument more concrete and more difficult for a payer to dismiss.

The American College of Rheumatology (ACR) has noted that failure to initiate appropriate treatment for certain conditions can result in irreversible joint damage within months. Documenting these time-sensitive risks gives the appeal urgency and clinical weight.

Applying the Framework in Practice

The four-element framework is most effective when it is integrated into clinical documentation templates rather than applied retrospectively. A note template for a high-denial medication might include specific fields:

1. Current findings: Diagnosis, objective data, severity metrics
2. Prior therapy: Drug/dose/duration/response for each prior treatment
3. Rationale: Why this treatment, citing guideline if applicable
4. Risk of non-treatment: Expected clinical trajectory without intervention

When these fields are populated at the point of care, the documentation simultaneously serves the clinician's care objectives and the practice's denial management needs. There is no separate step, no duplicate documentation, and no retrospective chart review when a denial arrives.

Common Documentation Failures

Understanding where documentation typically falls short helps practices identify their own vulnerabilities.

• Vague treatment history: "Patient failed prior therapy" without specifying which therapy, the dose, the duration, or the outcome. This is the single most common documentation failure in step therapy denials.
• Missing severity quantification: Describing a condition as "severe" or "significant" without measurable data to support the characterization. Payers do not accept subjective severity assessments as evidence of medical necessity.
• No guideline reference: Recommending a treatment that aligns with published guidelines without citing the guideline. The alignment is meaningless to a payer reviewer who does not know it exists.
• Absent risk assessment: Failing to document what happens if the treatment is not provided. Without this, the payer reviewer may conclude that delaying treatment to try an alternative carries acceptable risk.
• Diagnosis code mismatch: Documenting clinical findings that support a specific diagnosis but assigning a less specific ICD-10 code that does not meet the payer's coverage criteria for the requested service.

From Framework to Workflow

The transition from ad hoc documentation to a structured medical necessity framework does not require a technology overhaul. It requires a consistent approach: identify the medications and procedures with the highest denial rates in your practice, build documentation templates that address the four elements for those services, train clinical staff on the specific data points payers require, and audit documentation periodically to ensure compliance.

Practices that implement structured medical necessity documentation consistently report measurable improvements. First-pass approval rates increase because the documentation preemptively addresses payer criteria. Appeal turnaround times decrease because the clinical evidence is already assembled in the chart. Staff time spent on appeals decreases because the appeal letter is largely a reorganization of information that was documented at the point of care.

Medical necessity is not a payer construct to be fought — it is a clinical standard to be documented. When documentation is thorough, specific, and structured, medical necessity disputes resolve in the practice's favor far more often than not.